in economics from Duke University and an M.B.A
These effects are likely primarily mediated through actions in various regions of the brain involved in the regulation of appetite and food intake [18], as supported by preclinical studies [19,20,21,22], multiple human imaging studies [18], and the GLP-1R expression patterns in the human brain [9, 23]
Effectiveness Tirzepatide : Clinical studies show that Tirzepatide may lead to slightly greater weight loss than Semaglutide, with some patients losing up to 22.5% of their body weight
The metabolic benefits continue building without the tolerability challenges of the early weeks
Side effects like nausea or appetite loss are common early on but often improve
Did people without a gallbladder actually quit GLP-1 treatment more often